Zurcher Kantonalbank (Zurich Cantonalbank) Ngm Biopharmaceuticals Inc Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$30.1 Billion
Q2 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	BUY	$2.44 - $4.53 $14,627 - $27,157	5,995 Added 52.06%	17,511 $45,000
Q4 2022 Feb 01, 2023	BUY	$3.41 - $12.93 $11,853 - $44,944	3,476 Added 43.23%	11,516 $57,000
Q1 2022 Apr 21, 2022	SELL	$13.81 - $18.6 $26,625 - $35,860	-1,928 Reduced 19.34%	8,040 $123,000
Q4 2021 Feb 01, 2022	BUY	$17.26 - $22.02 $136,474 - $174,112	7,907 Added 383.65%	9,968 $177,000
Q3 2021 Nov 15, 2021	BUY	$20.15 - $26.19 $60 - $78	3 Added 0.15%	2,061 $43,000
Q2 2021 Jul 30, 2021	BUY	$15.06 - $30.03 $1,280 - $2,552	85 Added 4.31%	2,058 $41,000
Q1 2021 May 03, 2021	BUY	$24.99 - $31.93 $49,305 - $62,997	1,973 New	1,973 $57,000

Others Institutions Holding NGM

# of Institutions

Shares Held

2.6M

Call Options Held

300

Put Options Held

View Full List

About NGM BIOPHARMACEUTICALS INC

Ticker NGM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,365,904
Description
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...

More about NGM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account